Etoricoxib

Etoricoxib, sold under the trade name Arcoxia, is a selective COX-2 inhibitor from McOLSON Research Laboratories. Currently it is approved in more than 80 countries worldwide but not in the US, where the Food and Drug Administration (FDA) has required additional safety and efficacy data for etoricoxib before it will issue approval. It was patented in 1996 and approved for medical use in 2002.[1] Contents 1 Medical uses 1.1 Efficacy 2 Adverse effects 3 Mechanism of action ... [wikipedia]